Trust Co. of Oklahoma Buys 2,234 Shares of Zoetis Inc. (NYSE:ZTS)

Trust Co. of Oklahoma boosted its stake in shares of Zoetis Inc. (NYSE:ZTS) by 50.5% during the first quarter, Holdings Channel.com reports. The fund owned 6,654 shares of the company’s stock after acquiring an additional 2,234 shares during the period. Trust Co. of Oklahoma’s holdings in Zoetis were worth $1,126,000 at the end of the most recent reporting period.

Other hedge funds have also recently added to or reduced their stakes in the company. Peak Financial Advisors LLC bought a new position in Zoetis during the 4th quarter worth $2,776,000. Focus Financial Network Inc. ADV bought a new position in shares of Zoetis in the 4th quarter valued at $2,159,000. Price T Rowe Associates Inc. MD increased its stake in shares of Zoetis by 31.0% in the 4th quarter. Price T Rowe Associates Inc. MD now owns 13,716,681 shares of the company’s stock valued at $2,707,262,000 after purchasing an additional 3,244,074 shares during the last quarter. Ninety One UK Ltd increased its stake in shares of Zoetis by 13.1% in the 4th quarter. Ninety One UK Ltd now owns 108,293 shares of the company’s stock valued at $21,374,000 after purchasing an additional 12,537 shares during the last quarter. Finally, Raymond James Financial Services Advisors Inc. increased its stake in shares of Zoetis by 10.9% in the 4th quarter. Raymond James Financial Services Advisors Inc. now owns 183,564 shares of the company’s stock valued at $36,230,000 after purchasing an additional 17,976 shares during the last quarter. Institutional investors own 92.80% of the company’s stock.

Analyst Upgrades and Downgrades

ZTS has been the topic of several recent analyst reports. Stifel Nicolaus decreased their price target on Zoetis from $195.00 to $180.00 and set a “buy” rating on the stock in a research note on Tuesday, April 30th. HSBC decreased their price target on Zoetis from $230.00 to $225.00 and set a “buy” rating on the stock in a research note on Wednesday, May 8th. Piper Sandler reiterated an “overweight” rating and issued a $195.00 price target (down previously from $220.00) on shares of Zoetis in a research note on Tuesday, April 16th. Barclays cut their price objective on Zoetis from $260.00 to $230.00 and set an “overweight” rating on the stock in a report on Tuesday, April 23rd. Finally, The Goldman Sachs Group cut their price objective on Zoetis from $223.00 to $196.00 and set a “buy” rating on the stock in a report on Monday, May 6th. Eight analysts have rated the stock with a buy rating, According to MarketBeat, the company currently has an average rating of “Buy” and a consensus price target of $211.75.

Zoetis Price Performance

Shares of NYSE ZTS traded up $0.76 during mid-day trading on Wednesday, hitting $175.57. 1,251,745 shares of the stock traded hands, compared to its average volume of 2,941,580. The company has a market cap of $80.11 billion, a PE ratio of 33.83, a price-to-earnings-growth ratio of 2.69 and a beta of 0.86. Zoetis Inc. has a twelve month low of $144.80 and a twelve month high of $201.92. The firm has a 50 day simple moving average of $169.73 and a two-hundred day simple moving average of $178.25. The company has a debt-to-equity ratio of 1.30, a current ratio of 3.33 and a quick ratio of 1.94.

Zoetis (NYSE:ZTS) last announced its earnings results on Thursday, May 2nd. The company reported $1.38 EPS for the quarter, topping the consensus estimate of $1.34 by $0.04. The firm had revenue of $2.19 billion for the quarter, compared to the consensus estimate of $2.14 billion. Zoetis had a return on equity of 50.34% and a net margin of 27.38%. The business’s quarterly revenue was up 9.5% compared to the same quarter last year. During the same period in the previous year, the business earned $1.31 EPS. As a group, equities research analysts forecast that Zoetis Inc. will post 5.76 EPS for the current fiscal year.

Zoetis Announces Dividend

The business also recently announced a quarterly dividend, which will be paid on Wednesday, September 4th. Shareholders of record on Thursday, July 18th will be issued a dividend of $0.432 per share. This represents a $1.73 annualized dividend and a yield of 0.98%. The ex-dividend date of this dividend is Thursday, July 18th. Zoetis’s payout ratio is presently 33.33%.

Insiders Place Their Bets

In other Zoetis news, EVP Roxanne Lagano sold 923 shares of Zoetis stock in a transaction dated Thursday, April 18th. The stock was sold at an average price of $151.17, for a total transaction of $139,529.91. Following the transaction, the executive vice president now directly owns 14,800 shares of the company’s stock, valued at approximately $2,237,316. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Company insiders own 0.16% of the company’s stock.

Zoetis Profile

Zoetis Inc engages in the discovery, development, manufacture, and commercialization of animal health medicines, vaccines, and diagnostic products and services in the United States and internationally. The company commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep and others; and companion animals comprising dogs, cats, and horses.